Amarin Corp Plc (AMRN)

[biolover]

In jelis study epa showed survival but in the patient who already had history of CAD but it did improved to one who did not had CAD.. which i think is very difficult to prove. In out come study i think AMRN will go for people who already had history of CAD and if FDA agrees that would be huge. correct me if i am wrong.

And remember in marine trial epa did showed stastical significant reduction in APO -B and NON HDL C which by it self are considered major risk factor and if same holds true with anchor that will be great for AMRN.

Any thoughts?